Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02819310 · ClinicalTrials.gov registry record · Phase 3
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
A Phase 3 study of Constipation and Chronic Idiopathic Constipation, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 330
- Enrollment target
- 20
- Study locations
NCT02819310: Completed Phase 3 study of Constipation and Chronic Idiopathic Constipation, sponsored by Braintree Laboratories.
NCT02819310 is a Phase 3 study of Constipation and Chronic Idiopathic Constipation that has completed, run by Braintree Laboratories. The registered enrollment target is 330 participants, above the 199-participant average among 54 other Constipation trials with a reported enrollment target (66% higher). The trial reports 20 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02819310, a Phase 3 study of Constipation and Chronic Idiopathic Constipation, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 330 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of this study is to evaluate the safety of chronic use of BLI400 laxative in constipated adults.
Primary Outcome
% of subjects experiencing a treatment emergent adverse event during the 12 month treatment period
Conditions Studied
Interventions
- DRUG BLI400 Laxative
Study Locations (20)
Florida
- Braintree Research Site 13 - Brandon
- Braintree Research Site 3 - Brandon
- Braintree Research Site 18 - Hialeah
- Braintree Research Site 19 - Hialeah
- Braintree Research Site 4 - Miami
- Braintree Research Site 5 - Miami
- Braintree Research Site 16 - Miami
- Braintree Research Site 8 - Miami Lakes
- Braintree Research Site 17 - Palmetto Bay
- Braintree Research Site 12 - St. Petersburg
- Braintree Research Site 2 - West Palm Beach
Tennessee
- Braintree Research Site 11 - Chattanooga
- Braintree Research Site 22 - Memphis
- Braintree Research Site 10 - Nashville
California
- Braintree Research Site 14 - Corona
Kentucky
- Braintree Research Site 24 - Owensboro
Louisiana
- Braintree Research Site 15 - Lake Charles
Nevada
- Braintree Research Site 25 - Las Vegas
North Carolina
- Braintree Research Site 21 - Fayetteville
Ohio
- Braintree Research Site 6 - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2016-06 |
| Est. Completion | 2017-08 |
| Phase | Phase 3 |
What the finished NCT02819310 record still lists
NCT02819310 is an interventional study that assigns participants to a tested intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, above the 199-participant average among 54 other Constipation trials with a reported enrollment target (66% higher).
The record links to 3 conditions, with Constipation appearing as the primary indexed condition, and to 1 intervention - of which BLI400 Laxative is the first listed.
NCT02819310 names 20 study sites across 8 states, led by Florida, Tennessee, California.
Frequently Asked Questions
What is clinical trial NCT02819310 about?
NCT02819310 is a clinical study titled "An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults". The objective of this study is to evaluate the safety of chronic use of BLI400 laxative in constipated adults.
What is the current status of trial NCT02819310?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 330 participants. The study started on 2016-06. Estimated completion is 2017-08.
What conditions does trial NCT02819310 study?
This clinical trial studies the following conditions: Constipation, Chronic Idiopathic Constipation, CIC.
What interventions are being tested in trial NCT02819310?
The interventions under investigation include: BLI400 Laxative (DRUG).
Who is sponsoring clinical trial NCT02819310?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02819310 being conducted?
This trial has 20 study locations across California, Florida, Kentucky, Louisiana, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Constipation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02819310's enrollment target sits among peer trials
330 4th of 54 higher than 51 of 54 other Constipation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Constipation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessing Tenapanor as a Treatment of CF-related Constipation.
RECRUITING · Phase 3
-
Neostigmine and Glycopyrrolate by Iontophoresis
ACTIVE NOT RECRUITING · Phase 3
-
Study Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced Constipation
COMPLETED · Phase 3
-
Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
COMPLETED · Phase 3
-
Treatment of Functional Bowel Disorders
COMPLETED · Phase 3
-
A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia